Back to search
Advanced Dedifferentiated Liposarcoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Dedifferentiated Liposarcoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Dedifferentiated Liposarcoma trials you may qualify forThis early phase oncology trial will be conducted at various study centers to investigate the safety, tolerability, and antitumor activity of STC-15 (a METTL3 i…
This phase I trial tests the safety, side effects, and best dose of combination therapy with liposomal doxorubicin and peposertib in treating patients with sarc…
This phase I/II trial tests the side effects and best dose of abemaciclib when added to gemcitabine and compares the effectiveness of that treatment to the usua…
The purpose of this study is to find out whether mirdametinib in combination with palbociclib is an effective and safe treatment for people with metastatic, rec…
This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma.
This is a randomized, Open-label, Phase Ib/IIa study to evaluate the efficacy and safety of SPH4336 monotherapy or in combination with Cadonilimab in the patien…
This study is open to people with a type of cancer called dedifferentiated liposarcoma. People with advanced liposarcoma aged 18 or older who are not receiving…
This phase II trial compares the effect of treatment with palbociclib alone to treatment with palbociclib plus cemiplimab for treating patients with dedifferent…